| abstract |
The present application refers to a new tetrahydroquinoline derivative, a process for its preparation, its use alone or in combinations for the treatment and / or prevention of diseases, as well as its use for the preparation of drugs, especially as Cholesterol ester transfer protein (CETP) inhibitor for the treatment and / or prevention of cardiovascular diseases, especially hypolipoproteinemias, dyslipidemias, hypertriglycerideridemias, hyperlipidemias, hypercholesterolemias, and arteriosclerosis. |